{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:05:36Z","timestamp":1789243536186,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["RD12\/0019\/0001"],"award-info":[{"award-number":["RD12\/0019\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["EC11-007"],"award-info":[{"award-number":["EC11-007"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["RD16\/0011\/0001"],"award-info":[{"award-number":["RD16\/0011\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016145","name":"Ministerio de Sanidad, Consumo y Bienestar Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cell.2026.08.017","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:06:31Z","timestamp":1789139191000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycocalyx-edited mesenchymal stem\/stromal cell therapy in advanced osteoporosis"],"prefix":"10.1016","author":[{"given":"Jose M.","family":"Moraleda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garc\u00eda-Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Lozano-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Ruiz-Sar\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Blanquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Dolores","family":"L\u00f3pez-Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar\u00edo","family":"S\u00e1nchez-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Alguer\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Mar","family":"Molina-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ruiz-Espejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Peris-Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar M.","family":"Arrabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kiwitt-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Marras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-891X","authenticated-orcid":false,"given":"Robert","family":"Sackstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2026.08.017_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature01660","article-title":"Control of osteoblast function and regulation of bone mass","volume":"423","author":"Harada","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.08.017_bib2","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cell.2026.08.017_bib3","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cell.2026.08.017_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2026.08.017_bib5","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal Osteoporosis","volume":"389","author":"Walker","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.stem.2012.02.003","article-title":"Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration","volume":"10","author":"Park","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cell.2026.08.017_bib7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10529-011-0541-8","article-title":"A comparison between osteogenic differentiation of human unrestricted somatic stem cells and mesenchymal stem cells from bone marrow and adipose tissue","volume":"33","author":"Shafiee","year":"2011","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.cell.2026.08.017_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1172\/JCI70050","article-title":"Bone marrow mesenchymal stem cells and TGF-beta signaling in bone remodeling","volume":"124","author":"Crane","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.08.017_bib9","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/emm.2013.94","article-title":"Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine","volume":"45","author":"Murphy","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib10","first-page":"416","article-title":"Human osteoblast-like cells expressing MHC class II determinants stimulate allogeneic and autologous peripheral blood mononuclear cells and function as antigen-presenting cells","volume":"68","author":"Skj\u00f8dt","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.cell.2026.08.017_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1359\/JBMR.051004","article-title":"Immunocompetent properties of human osteoblasts: interactions with T lymphocytes","volume":"21","author":"Stanley","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.2009.00792.x","article-title":"Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration","volume":"230","author":"Sackstein","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cell.2026.08.017_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/glycob\/cww026","article-title":"Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology","volume":"26","author":"Sackstein","year":"2016","journal-title":"Glycobiology"},{"key":"10.1016\/j.cell.2026.08.017_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1703","article-title":"Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone","volume":"14","author":"Sackstein","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nature03703","article-title":"In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment","volume":"435","author":"Sipkins","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.08.017_bib16","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1182\/blood-2015-01-607366","article-title":"Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation","volume":"125","author":"Popat","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.08.017_bib17","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/stem.2435","article-title":"Glycoengineering of E-Selectin Ligands by intracellular versus extracellular fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells","volume":"34","author":"Dykstra","year":"2016","journal-title":"Stem Cells (Dayt. Ohio)"},{"key":"10.1016\/j.cell.2026.08.017_bib18","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/stem.2549","article-title":"A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells","volume":"35","author":"Pach\u00f3n-Pe\u00f1a","year":"2017","journal-title":"Stem Cells (Dayt. Ohio)"},{"key":"10.1016\/j.cell.2026.08.017_bib19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jcyt.2018.07.001","article-title":"Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications","volume":"20","author":"L\u00f3pez-Lucas","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cell.2026.08.017_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MOH.0b013e3283476140","article-title":"The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives","volume":"18","author":"Sackstein","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cell.2026.08.017_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMra2304431","article-title":"Stem-Cell Aging and Pathways to Precancer Evolution","volume":"389","author":"Jamieson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C","article-title":"Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics","volume":"75","author":"Rodr\u00edguez","year":"1999","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cell.2026.08.017_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.33176\/AACB-20-0001","article-title":"The Role of PINP in Diagnosis and Management of Metabolic Bone Disease","volume":"42","author":"Gillett","year":"2021","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.cell.2026.08.017_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0004563213515190","article-title":"Biochemical markers of bone turnover - uses and limitations","volume":"51","author":"Hlaing","year":"2014","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cell.2026.08.017_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00198-017-3906-6","article-title":"International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates","volume":"28","author":"Diez-Perez","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cell.2026.08.017_bib26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMsb1006120","article-title":"The ethics of placebo in studies with fracture end points in osteoporosis","volume":"363","author":"Stein","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib28","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1038\/s41409-020-0910-9","article-title":"Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile","volume":"55","author":"van der Wagen","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cell.2026.08.017_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1177\/15353702231194250","article-title":"The U.S. Food and Drug Administration, the mechanism of action, and other considerations for cell-based therapy candidates","volume":"248","author":"Caplan","year":"2023","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.cell.2026.08.017_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s13287-021-02609-x","article-title":"The safety of MSC therapy over the past 15 years: a meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.cell.2026.08.017_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.mad.2007.12.002","article-title":"Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies","volume":"129","author":"Stolzing","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.cell.2026.08.017_bib32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1359\/jbmr.1999.14.7.1115","article-title":"Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow","volume":"14","author":"D'Ippolito","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jcb.1174","article-title":"Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges","volume":"82","author":"Mueller","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cell.2026.08.017_bib34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcyt.2015.11.017","article-title":"Chromosomal stability of mesenchymal stromal cells during in vitro culture","volume":"18","author":"Stultz","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cell.2026.08.017_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.reth.2022.06.003","article-title":"Safety of using cultured cells with trisomy 7 in cell therapy for treating osteoarthritis","volume":"21","author":"Mizuno","year":"2022","journal-title":"Regen. Ther."},{"key":"10.1016\/j.cell.2026.08.017_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12943-017-0597-8","article-title":"Mesenchymal stem cells: key players in cancer progression","volume":"16","author":"Ridge","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cell.2026.08.017_bib37","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood-2009-05-219907","article-title":"Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation","volume":"115","author":"Tarte","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.08.017_bib38","doi-asserted-by":"crossref","first-page":"e950","DOI":"10.1038\/cddis.2013.480","article-title":"Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cell.2026.08.017_bib39","doi-asserted-by":"crossref","first-page":"100249","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.cell.2026.08.017_bib40","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The Pros and Cons of Mesenchymal Stem Cell-Based Therapies","volume":"28","author":"Musia\u0142-Wysocka","year":"2019","journal-title":"Cell Transplant."},{"key":"10.1016\/j.cell.2026.08.017_bib41","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cell.2026.08.017_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0042-1755328","article-title":"Mesenchymal Stem Cell Transplantation in Liver Diseases","volume":"42","author":"Nevens","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cell.2026.08.017_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/ten.teb.2014.0090","article-title":"An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts","volume":"20","author":"Aoyama","year":"2014","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.cell.2026.08.017_bib44","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3390\/jcm12062117","article-title":"Long-Term Results of a Phase I\/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis","volume":"12","author":"Blanco","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib45","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s12015-021-10192-0","article-title":"Intravenously Infused Stem Cells for Cancer Treatment","volume":"17","author":"Mercer-Smith","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.cell.2026.08.017_bib46","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3390\/bioengineering10101187","article-title":"Mesenchymal Stem\/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients","volume":"10","author":"Baron","year":"2023","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.cell.2026.08.017_bib47","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/TP.0000000000002605","volume":"103","author":"Smets","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.cell.2026.08.017_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14653240902753477","article-title":"Cell therapy for disorders of bone","volume":"11","author":"Jethva","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cell.2026.08.017_bib49","doi-asserted-by":"crossref","first-page":"e151922","DOI":"10.1172\/jci.insight.151922","article-title":"Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa","volume":"6","author":"Kiritsi","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.cell.2026.08.017_bib50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cell.2005.02.006","article-title":"Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone","volume":"120","author":"Chien","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.08.017_bib51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jbmr.1476","article-title":"Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women","volume":"27","author":"Gehlbach","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib52","doi-asserted-by":"crossref","first-page":"115286","DOI":"10.1016\/j.bone.2020.115286","article-title":"Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older","volume":"134","author":"S\u00f6reskog","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.cell.2026.08.017_bib53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41584-023-00935-3","article-title":"Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone","volume":"19","author":"Ferrari","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cell.2026.08.017_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161435.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2016","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cell.2026.08.017_bib55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4158\/GL-2020-0524","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis- 2020 Update Executive Summary","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cell.2026.08.017_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.cell.2026.08.017_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.3039","article-title":"Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis","volume":"32","author":"Cummings","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib58","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/bcp.13791","article-title":"Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective","volume":"85","author":"Kehoe","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cell.2026.08.017_bib59","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","article-title":"Rapid and robust response of biochemical markers of bone formation to teriparatide therapy","volume":"45","author":"Glover","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.cell.2026.08.017_bib61","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1210\/jc.2005-1712","article-title":"Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis","volume":"91","author":"Bauer","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cell.2026.08.017_bib62","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.08.017_bib63","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S2213-8587(19)30255-4","article-title":"Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial","volume":"7","author":"Tsai","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cell.2026.08.017_bib64","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.3198","article-title":"Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study","volume":"32","author":"Tsai","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib65","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","article-title":"Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial","volume":"390","author":"Langdahl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2026.08.017_bib66","doi-asserted-by":"crossref","first-page":"ziae016","DOI":"10.1093\/jbmrpl\/ziae016","article-title":"Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study","volume":"8","author":"Adami","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/j.cell.2026.08.017_bib67","doi-asserted-by":"crossref","first-page":"907914","DOI":"10.3389\/fendo.2022.907914","article-title":"Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future","volume":"13","author":"Chavassieux","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cell.2026.08.017_bib68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jbmr.1482","article-title":"QCT measures of bone strength at the thoracic and lumbar spine: the Framingham Study","volume":"27","author":"Samelson","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib69","doi-asserted-by":"crossref","first-page":"895474","DOI":"10.1155\/2013\/895474","article-title":"Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women","volume":"2013","author":"Li","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.cell.2026.08.017_bib70","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1007\/s00330-019-06018-w","article-title":"Improved prediction of incident vertebral fractures using opportunistic QCT compared to DXA","volume":"29","author":"L\u00f6ffler","year":"2019","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.cell.2026.08.017_bib71","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","article-title":"Executive summary of the 2015 ISCD position development conference on advanced measures From DXA and QCT: Fracture prediction Beyond BMD","volume":"18","author":"Shepherd","year":"2015","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.cell.2026.08.017_bib72","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cell.2026.08.017_bib73","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1126\/science.aav4040","article-title":"The genomic history of the Iberian Peninsula over the past 8000 years","volume":"363","author":"Olalde","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.08.017_bib74","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s11307-010-0439-1","article-title":"Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT\/CT in vivo","volume":"13","author":"Gildehaus","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.cell.2026.08.017_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-62703-989-5_10","article-title":"Tips and techniques for processing and sectioning undecalcified murine bone specimens","volume":"1130","author":"Bemenderfer","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2026.08.017_bib76","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cell.2026.08.017_bib77","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1118\/1.3481509","article-title":"Assessment of 2D and 3D fractal dimension measurements of trabecular bone from high-spatial resolution magnetic resonance images at 3 T","volume":"37","author":"Alberich-Bayarri","year":"2010","journal-title":"Med. Phys."},{"key":"10.1016\/j.cell.2026.08.017_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rx.2013.06.001","article-title":"Reproducibility and accuracy in the morphometric and mechanical quantification of trabecular bone from 3 Tesla magnetic resonance images","volume":"56","author":"Alberich-Bayarri","year":"2014","journal-title":"Radiologia"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742600944X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009286742600944X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:26:25Z","timestamp":1789241185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009286742600944X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":78,"alternative-id":["S009286742600944X"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2026.08.017","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycocalyx-edited mesenchymal stem\/stromal cell therapy in advanced osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}